Funding Opportunities and Notices

NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest. Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts   November 24, 2021 Notice of Changes to Funding Opportunities Notice of Correction in RFA-CA-21-060, "NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)" (NOT-CA-22-015) National Cancer Institute Notice of Correction in RFA-CA-21-061, "NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required)" (NOT-CA-22-016) National Cancer Institute Notice of Correction in RFA-CA-21-062, "NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)" (NOT-CA-22-017) National Cancer Institute Notices of Special Interest Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research (NOT-AI-22-004) National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Cancer Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of Special Interest: Administrative Supplements on High Priority Topic Areas for NCCIH Grants (NOT-AT-22-002) National Center for Complementary and Integrative Health Notice of Special Interest (NOSI): Administrative Supplements for NCCIH Grants to Support Pain-Focused High Priority Research Areas (NOT-AT-22-003) National Center for Complementary and Integrative Health Notice of Special Interest: Expanding the Otitis Media Research Workforce: Focus on Early Stage Investigators (NOT-DC-22-001) National Institute on Deafness and Other Communication Disorders Notice of Special Interest (NOSI): Basic and Translational Oral Health Research Related to HIV/AIDS (NOT-DE-21-019) National Institute of Dental and Craniofacial Research Notice of Special Interest (NOSI): Availability of Administrative Supplements to INBRE Awards to Fund Research Collaborations (NOT-GM-22-001) National Institute of General Medical Sciences Office of Research on Women's Health Notice of Special Interest (NOSI): Limited Competition for Administrative Supplements to Accelerate the Development of a Translational Research Resource Platform for Advancing Maternal Precision Therapeutics (NOT-HD-21-051) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of Special Interest (NOSI): Examining Effects of HIV Pre-Exposure Prophylaxis (PrEP) on Heart, Lung, Blood, and Sleep Function (NOT-HL-21-025) National Heart, Lung, and Blood Institute Funding Opportunities Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) (PAR-22-071) National Cancer Institute Application Receipt Date(s): November 17, 2024 Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) (PAR-22-072) National Institute on Minority Health and Health Disparities National Cancer Institute National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of Mental Health Office of Behavioral and Social Sciences Research Office of Disease Prevention Application Receipt Date(s): Multiple dates, see announcement. Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (RFA-CA-22-001) National Cancer Institute Application Receipt Date(s): September 22, 2022 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (RFA-CA-22-002) National Cancer Institute Application Receipt Date(s): September 22, 2022 Analysis, Technology, Leadership, Administration and Science (ATLAS) Center (U24 Clinical Trial Not Allowed) (RFA-DK-21-034) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): March 24, 2022 Development of Advanced Analytical Methods for Analyzing Diastereomer Compositions in Oligonucleotides (U01) Clinical Trial Not Allowed (RFA-FD-22-013) Food and Drug Administration Application Receipt Date(s): February 7, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA. Centers for Agricultural Safety and Health (U54) (RFA-OH-22-002) National Institute for Occupational Safety and Health Application Receipt Date(s): November 30, 2024   NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site.

HOME  |  DISCLAIMER  |  POLICIES  |  ACCESSIBILITY  |  FOIA  |  NEWS  |  CONTACT US

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892